Amneal PharmaceuticalsvsThermo Fisher Scientific

AMRX and TMO stock compared: price, dividend, valuation and results, from SEC filings.

AMRX

Amneal Pharmaceuticals, Inc.

$21.38

Value $7.4B

-1.47%
AMRX's page

TMO

Thermo Fisher Scientific Inc

$700.22

Value $260B

+0.11%
TMO's page

Amneal Pharmaceuticals (AMRX) has a market value of $7.4B and Thermo Fisher Scientific (TMO) $260B. Over the last year, with dividends, AMRX moved +79.7% and TMO +19.5%. The P/E is 55.9 for AMRX and 36.8 for TMO. Dividend yield: AMRX none, TMO 0.26%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMRX$7.4B

    TMO$260B

    TMO is 35 times AMRX

  • Revenue, 12 months

    AMRX$3.2B

    TMO$47.4B

    TMO is 15 times AMRX

  • Net income, 12 months

    AMRX$133M

    TMO$7.1B

    TMO is 53 times AMRX

  • Operating margin

    AMRX15.0%

    TMO17.9%

    2.9 points apart

  • ROIC

    AMRX16.7%

    TMO8.2%

    8.5 points apart

  • P/E

    AMRX55.9

    TMO36.8

    AMRX is 1.5 times TMO

  • Dividend yield

    AMRX0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    AMRX+310.4%

    TMO+11.8%

    298.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMRX+310.4%

TMO+11.8%

20040020222023202420252026
Returns by period
PeriodAMRXWith dividendsTMOWith dividends
1 year since November 12, 2025+79.7%Price +79.7%+19.5%Price +19.1%
3 years since November 13, 2023+399.5%+70.9% a yearPrice +399.5%+58.8%+16.7% a yearPrice +57.3%
5 years since November 12, 2021+310.4%+32.6% a yearPrice +310.4%+11.8%+2.3% a yearPrice +10.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMRXAmneal PharmaceuticalsTMOThermo Fisher Scientific

Valuation

AMRXTMO
Valuation
Price$21.38$700.22
Market value$7.4B$260B
Enterprise value (EV)$10.3B$295B
P/E55.936.8
P/E, 5-year median–32.7
P/B14.04.8
EV/EBIT21.534.9
Free cash flow yield1.2%2.9%

Results and growth

AMRXTMO
Results and growth
Revenue, 12 months$3.2B$47.4B
Net income, 12 months$133M$7.1B
Free cash flow, 12 months$88M$7.6B
Earnings per share, 12 months$0.42$18.96
Revenue growth, year on year8.1%3.9%
Revenue growth a year, past+8.7%over 5 years+6.7%over 5 years
EPS growth a year, past-18.5%over 5 years+2.1%over 5 years

Margins and returns on capital

AMRXTMO
Margins and returns on capital
Gross margin40.2%–
Operating margin15.0%17.9%
Net margin4.2%14.9%
ROIC16.7%8.2%
ROE196.8%13.4%

Balance sheet

AMRXTMO
Balance sheet
Cash$157M$6.1B
Total debt$3.0B$41.4B
Net debt / EBITDA5.33.7
Interest cover–5.5×

Dividends and buybacks

AMRXTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMRX or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Amneal Pharmaceuticals or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($260B) is about 34.9 times Amneal Pharmaceuticals ($7.4B), at today's prices.

How did AMRX and TMO stock do over the last 5 years?

Since November 12, 2021, AMRX's price moved +310.4% and TMO's +10.2%. With dividends: AMRX +310.4% (+32.6% a year), TMO +11.8% (+2.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMRX or TMO?

The dividend yield at today's price is none for Amneal Pharmaceuticals and 0.26% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of AMRX and TMO?

At today's price, the P/E is 55.9 for AMRX and 36.8 for TMO. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Amneal Pharmaceuticals or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 4.2% for Amneal Pharmaceuticals and 14.9% for Thermo Fisher Scientific, and the operating margin 15.0% and 17.9%. Revenue was $3.2B and $47.4B.

Which is the better investment, Amneal Pharmaceuticals or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.